- Design
- Prospective population pharmacokinetic study
- Population
- 15 term neonates with hypoxic-ischaemic encephalopathy under therapeutic hypothermia
- Primary outcome
- Levetiracetam pharmacokinetic parameters and covariates
- Effect
- Clearance 4.27 L/h (15% IIV); rose with creatinine clearance and sodium
LEVNEONAT-1 measured levetiracetam pharmacokinetics in 15 term neonates treated for seizures due to hypoxic-ischaemic encephalopathy during therapeutic hypothermia. Babies received a loading dose of 30 to 60 mg/kg, then a quarter of that dose every eight hours.
A two-compartment model fitted the data. Typical clearance was 4.27 L/h scaled to body weight. Clearance rose with creatinine clearance and with serum sodium. There was no relationship between early drug exposure and the reduction in seizure burden.
Levetiracetam is increasingly used first or second line in neonatal seizures. This small study supports adjusting maintenance dosing for renal function in cooled babies, and raises sodium as a possible marker of encephalopathy severity. The lack of an exposure–response link in 15 babies says little either way about efficacy.
- Consider renal function when setting levetiracetam maintenance doses in cooled neonates.
- Note that hyponatraemia was associated with lower clearance and higher exposure.
- Do not infer efficacy from this study; it was too small to test it.
- Follow local neonatal seizure protocols for drug choice.
Why it matters
Cooling and kidney injury both slow drug clearance in the babies most likely to need anticonvulsants.
Don't overread it
Fifteen babies; it describes kinetics, not whether levetiracetam works.
The statistics, in plain English
Population pharmacokinetic models estimate typical values and how much they vary between babies. With 15 babies, covariate findings such as sodium are early signals that need confirming.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for clinical pharmacology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free